01 Shift Toward FHIR-Based Interoperable e-Prescribing Networks The e-prescribing market analysis indicates that demand for seamless exchange of prescription and patient data across EHRs, pharmacies, and payers is shifting e-prescribing toward FHIR-based interoperable networks, allowing medication information to move through standardized APIs rather than isolated systems; as of July 2026, CMS-aligned networks are required to support FHIR APIs using standardized medication terminology such as RxNorm.
02 Development of AI-Assisted Prescription Order Generation Advances in generative AI and clinical decision-support technologies are also supporting AI-assisted prescription order generation, where patient and medication data can help clinicians create and review orders with greater consistency; a 2026 randomized study of 77 pharmacists and trainees found that AI assistance increased overall medication-order verification accuracy, although incorrect AI recommendations also created a risk of automation bias.
01 Rising Demand for Medication Error Reduction and Increasing Adoption of Electronic Health Records Drive Market The rising demand for medication error reduction is increasing adoption of e-prescribing systems that improve prescription accuracy and reduce manual transcription risks. Electronic prescriptions provide structured medication details, dosage instructions, and patient information, supporting safer prescribing workflows. For example, electronic prescribing can flag potential drug interactions or duplicate medications before an order reaches the pharmacy. Higher focus on medication safety increases demand from hospitals, clinics, and pharmacies for reliable e-prescribing platforms. This need for safer medication management therefore supports growth in the e-prescribing market.The increasing adoption of electronic health records is expanding demand for e-prescribing systems that connect medication orders with digital patient records. Integrated prescribing workflows allow clinicians to access medication histories and record new prescriptions within the same clinical environment. For example, a physician can review a patient's current medications in an EHR before sending a prescription electronically to a pharmacy. Greater EHR adoption encourages healthcare providers to procure connected prescribing capabilities and expands the addressable user base for e-prescribing vendors. This integration of prescribing with digital clinical workflows therefore supports market growth.
01 High Implementation and Software Costs and Complex Integration with Existing EHR Systems Restrain Market Expansion High costs for software licenses, system configuration, customization, training, and ongoing maintenance can create a substantial financial burden for healthcare providers. These expenses can be difficult for smaller practices and facilities with limited technology budgets to manage. Such cost barriers can delay implementation and limit adoption of e prescribing systems.Compatibility issues between e prescribing platforms and existing EHR systems can make implementation technically complex. Additional integration, customization, and data-mapping requirements can increase deployment time and operational costs. These challenges can disrupt existing workflows and slow adoption across healthcare facilities.
01 Expansion of E-Prescribing in Specialty Pharmacy and Growth of E-Prescribing for Veterinary Care Offer Growth Opportunities Specialty pharmacies, healthcare providers, and e-prescribing software companies can address complex medication workflows for oncology, autoimmune, and rare-disease treatments. Companies such as Surescripts can generate additional revenue through specialty pharmacy connectivity, prescription routing, and related transaction services.Veterinary clinics, animal-health providers, and veterinary pharmacy platforms can use electronic prescriptions to streamline medication ordering, refills, and pharmacy coordination. Companies such as Covetrus can expand revenue through veterinary pharmacy services, prescription-management platforms, and related digital solutions.
01 Cybersecurity and Prescription Fraud Risks and Medication Availability and Pharmacy Fulfillment Constraints Hinders Growth The expansion of electronic prescribing creates additional exposure to identity misuse and fraudulent prescription activity, requiring stronger authentication and monitoring. The U.S. DEA reported an increase in fraudulent e-prescriptions between 2021 and 2023, including misuse of prescriber registration numbers and identities, increasing compliance and security requirements for providers.E-prescribing can transmit prescriptions efficiently, but shortages of specific medicines can still prevent pharmacies from fulfilling them, limiting the practical value of digital prescribing. For example, the U.S. stimulant shortage beginning in 2022 created fulfillment constraints despite continued electronic prescribing, requiring prescribers and pharmacies to manage alternative medicines and availability.
April 2026 Surescripts expanded its e-prescribing network by introducing AI-powered prescription decision support, enhanced medication history services, and real-time prescription benefit capabilities for healthcare providers.
February 2026 Oracle Health (formerly Cerner) launched upgraded e-prescribing solutions integrated with AI-assisted clinical workflows, electronic health records (EHRs), and pharmacy connectivity.
October 2025 Epic Systems Corporation expanded its e-prescribing platform with enhanced medication management, electronic prior authorization (ePA), and interoperability features supporting hospital and ambulatory care providers.
June 2025 athenahealth introduced enhanced cloud-based e-prescribing capabilities with integrated clinical decision support, medication adherence tools, and pharmacy workflow automation.